東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Personalization in gynecologic oncology

Mandai, Masaki.

Linked to FindBook

Google Book

Amazon

博客來

Personalization in gynecologic oncology

Record Type:	Electronic resources : Monograph/item
Title/Author:	Personalization in gynecologic oncology/ edited by Masaki Mandai.
other author:	Mandai, Masaki.
Published:	Singapore :Springer Nature Singapore : : 2022.,
Description:	v, 147 p. :ill., digital ;24 cm.
[NT 15003449]:	1 Personalized treatment in ovarian cancer -- 2 Carcinogenesis and personalization in hpv-associated precancer lesions of the cervix -- 3 Personalized treatment for gestational trophoblastic tumor -- 4 Personalized treatment in uterine sarcoma -- 5 Clinical relevance of brca1/2 pathogenic variants and impaired dna repair pathways in ovarian carcinomas -- 6 Personalized treatment in immunotherapy for gynecologic cancer -- 7 Risk assessment and prevention strategies for hereditary gynecological cancers -- 8 How genome-wide analysis contributes to personalized treatment in cancers including gynecologic cancers -- 9 Personalized treatment of gynecological cancer according to age and symptom benefit.
Contained By:	Springer Nature eBook
Subject:	Generative organs, Female - Cancer -
Online resource:	https://doi.org/10.1007/978-981-19-4711-7
ISBN:	9789811947117

Personalization in gynecologic oncology
Personalization in gynecologic oncology[electronic resource] /edited by Masaki Mandai. - Singapore :Springer Nature Singapore :2022. - v, 147 p. :ill., digital ;24 cm. - Comprehensive gynecology and obstetrics,2364-219X. - Comprehensive gynecology and obstetrics..

1 Personalized treatment in ovarian cancer -- 2 Carcinogenesis and personalization in hpv-associated precancer lesions of the cervix -- 3 Personalized treatment for gestational trophoblastic tumor -- 4 Personalized treatment in uterine sarcoma -- 5 Clinical relevance of brca1/2 pathogenic variants and impaired dna repair pathways in ovarian carcinomas -- 6 Personalized treatment in immunotherapy for gynecologic cancer -- 7 Risk assessment and prevention strategies for hereditary gynecological cancers -- 8 How genome-wide analysis contributes to personalized treatment in cancers including gynecologic cancers -- 9 Personalized treatment of gynecological cancer according to age and symptom benefit.

This book thoroughly illustrates the designed and tailored medical approaches for tumors of the female reproductive organ. The chapters explore different cancer species such as ovarian cancer, endometrial cancer, cervical cancer, etc. Various treatment modalities such as immunotherapy and histotype-specific treatment are delivered, and it offers a chapter on how genome-wide analysis contributes to personalized treatment. It is essential to understand this concept because many molecular target drugs and the prevalence of genome-based analysis in clinical settings have enabled us to introduce valid precision medicine in the field of gynecologic oncology. Chapters explain the stream of transition from conventional standardized treatment to personalized treatment and address future perspectives. Personalization Gynecologic Oncology is a well-designed source for beginning to advanced oncologists, gynecologists, geneticists, genetic counselors, and nurses. Offering the latest treatment strategies, the Editor hopes the ideas presented here will be a foundation for further development in the field.

ISBN: 9789811947117

Standard No.: 10.1007/978-981-19-4711-7doiSubjects--Topical Terms:

2057858
Generative organs, Female
--Cancer

LC Class. No.: RC280.G5 / P47 2022

Dewey Class. No.: 616.99465

Personalization in gynecologic oncology
LDR:02843nmm a2200337 a 4500 001 2305140
003 DE-He213
005 20221025170704.0
006 m d
007 cr nn 008maaau
008 230409s2022 si s 0 eng d
020 $a 9789811947117 $q (electronic bk.)
020 $a 9789811947100 $q (paper)
024 7 $a 10.1007/978-981-19-4711-7 $2 doi
035 $a 978-981-19-4711-7
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.G5 $b P47 2022
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.99465 $2 23
090 $a RC280.G5 $b P467 2022
245 0 0 $a Personalization in gynecologic oncology $h [electronic resource] / $c edited by Masaki Mandai.
260 $a Singapore : $b Springer Nature Singapore : $b Imprint: Springer, $c 2022.
300 $a v, 147 p. : $b ill., digital ; $c 24 cm.
490 1 $a Comprehensive gynecology and obstetrics, $x 2364-219X
505 0 $a 1 Personalized treatment in ovarian cancer -- 2 Carcinogenesis and personalization in hpv-associated precancer lesions of the cervix -- 3 Personalized treatment for gestational trophoblastic tumor -- 4 Personalized treatment in uterine sarcoma -- 5 Clinical relevance of brca1/2 pathogenic variants and impaired dna repair pathways in ovarian carcinomas -- 6 Personalized treatment in immunotherapy for gynecologic cancer -- 7 Risk assessment and prevention strategies for hereditary gynecological cancers -- 8 How genome-wide analysis contributes to personalized treatment in cancers including gynecologic cancers -- 9 Personalized treatment of gynecological cancer according to age and symptom benefit.
520 $a This book thoroughly illustrates the designed and tailored medical approaches for tumors of the female reproductive organ. The chapters explore different cancer species such as ovarian cancer, endometrial cancer, cervical cancer, etc. Various treatment modalities such as immunotherapy and histotype-specific treatment are delivered, and it offers a chapter on how genome-wide analysis contributes to personalized treatment. It is essential to understand this concept because many molecular target drugs and the prevalence of genome-based analysis in clinical settings have enabled us to introduce valid precision medicine in the field of gynecologic oncology. Chapters explain the stream of transition from conventional standardized treatment to personalized treatment and address future perspectives. Personalization Gynecologic Oncology is a well-designed source for beginning to advanced oncologists, gynecologists, geneticists, genetic counselors, and nurses. Offering the latest treatment strategies, the Editor hopes the ideas presented here will be a foundation for further development in the field.
650 0 $a Generative organs, Female $x Cancer $x Treatment. $3 2057858
650 0 $a Personalized medicine. $3 2134267
650 1 4 $a Oncology. $3 751006
650 2 4 $a Gynecology. $3 618102
650 2 4 $a Cancer Genetics and Genomics. $3 3591654
650 2 4 $a Tumour Biomarkers. $3 3597478
700 1 $a Mandai, Masaki. $3 3607974
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
830 0 $a Comprehensive gynecology and obstetrics. $3 3259247
856 4 0 $u https://doi.org/10.1007/978-981-19-4711-7
950 $a Medicine (SpringerNature-11650)